News from Spyryx Biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 16, 2017, 08:00 ET Spyryx Biosciences to Present at American Thoracic Society International Conference May 19- 24, 2017, Washington, DC

Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases,...


May 05, 2017, 08:00 ET Spyryx Biosciences Partners with Cystic Fibrosis Canada, Serves as Presenting Sponsor of the 16th Broken Arrow Conference May 4-6, Toronto, Ontario

Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung disease, announced...


Apr 05, 2017, 08:00 ET Spyryx Biosciences Presents Data and Corporate Update at Two Recent Conferences in Support of Clinical Candidate for Cystic Fibrosis

Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, recently...


Mar 30, 2017, 08:00 ET Spyryx Biosciences to Present at the Needham Healthcare Conference Tuesday, April 4, 2017 New York, N.Y.

Spyryx Biosciences, a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, announced today...


Feb 28, 2017, 08:00 ET Spyryx Biosciences Marks Rare Disease Day With an Update on Clinical Trials for SPX-101

Spyryx Biosciences, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, today...


Feb 06, 2017, 08:01 ET Spyryx Biosciences Announces Successful Completion of Phase 1 Clinical Trial for SPX-101 and Planned Phase 2 Initiation in Cystic Fibrosis During 2017

Spyryx Biosciences, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, today...


Nov 02, 2016, 08:00 ET Spyryx Biosciences Presents Data at NACFC on SPX-101 Demonstrating Efficacy, Safety, and Stability in Animal Models

Three posters presented by Spyryx Biosciences at the North American Cystic Fibrosis Conference provided data that demonstrates the safety,...


Oct 25, 2016, 08:00 ET Spyryx Biosciences to Present Safety, Stability & Effectiveness Data for SPX-101 at the North American Cystic Fibrosis Conference October 27-29, 2016 Orlando, FL

Spyryx Biosciences, a clinical-stage biopharmaceutical company developing first-in-class innovative therapeutics to address severe lung diseases,...


Oct 03, 2016, 08:00 ET Spyryx Biosciences Presents Development Update at Jefferies Cystic Fibrosis Summit

 John Taylor, President and CEO of Spyryx Biosciences, a clinical-stage biopharmaceutical company developing innovative therapeutics to address...


Sep 26, 2016, 08:14 ET Spyryx Biosciences to Present at Jefferies Cystic Fibrosis Summit

 Spyryx Biosciences, a clinical stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, announced...